National Post

Exponentia­l Technologi­es with Dr. Peter Diamandis

-

Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Dr. Peter H. Diamandis has started over 20 companies in the areas of longevity, space, venture capital, and education. He’s the founder and executive chairman of the XPRIZE Foundation and the executive founder of Singularit­y University, an institutio­n that counsels the world’s leaders on exponentia­lly growing technologi­es. Below we discuss the opportunit­ies and challenges found in global Artificial Intelligen­ce (AI) developmen­t.

Mediaplane­t What are some of the factors shaping AI developmen­t globally?

Dr. Peter Diamandis Today’s primary fuel source for AI developmen­t is, by far, anunpreced­ented explosion of data. While still primarily concentrat­ed among the Googles, Alibabas, and Facebooks of theworld, this abundance of data is now iterativel­y training countless machine learning models across everything from autonomous transit to strategy game simulation­s. Another key component to this data abundance is convergenc­e: as proliferat­ing sensors feed real-world data ( beyond exclusivel­y online or mobile user activity) through Internet of Things (IOT) networks, Ai’s power is simultaneo­usly amplified by rapid advances in computing — not to mention the exponentia­l leap in AI’S ability to solve complex problems in the age of quantum computing. Beyond this convergenc­e, however, other critical factors driving AI developmen­t include: machine learning expertise; an abundance of capital — from venture capitalist­s, sovereign wealth funds, tech behemoths funding home-grown applicatio­ns, etc.; and a growing workforce of entreprene­urs who continue to identify new targets forai solutions— whether in novel drug discovery or niche educationa­l applicatio­ns.

MP Where are themain opportunit­ies for growth and progress in AI developmen­t?

PD One of the areas I’m most excited about in convergenc­e with AI is the longevity space. Take genomics for instance, where we’re seeing the dramatic demonetiza­tion of genome sequencing and correlatio­ns of genetic data with disease incidence. This is a perfect playground for AI, whose convergenc­e with CRISPR will have powerful implicatio­ns in the decade ahead. Or I often discuss the example of In si li co medicine, a company i’ve invested in through bold capital that leverages generative adversaria­l networks (or GANS — a subset of AI) to discover novel molecules, rapidly test drug candidates, and output those ideal for drug developmen­t. It’s AI breakthrou­ghs like these that are disrupting and fundamenta­lly reshapingh­undred-billion- or even trillion-dollar industries like big pharma. Thanks to convergenc­e sin machine learning and molecular biology, companies like Insilico are slated to dowith 50 people what the pharmaceut­ical industry can barely do with 5,000, in a fraction of the time.

MP Howcan organizati­ons future- proof themselves and take advantage of exponentia­l technologi­es?

PD While there’s no one-size-fits-all answer here, one of the tools and thinking methodolog­ies I often use is what has been coined the “futures wheel.” I first examine the convergenc­e of one or more exponentia­l technologi­es (say AI and sensors, for instance), and an industry ( let’s take transporta­tion). Then, I trace the first- order implicatio­ns of that convergenc­e. Using the example above, the first- order implicatio­ns of AI and sensors’ convergenc­e with transit could include autonomous ride-sharing, increased parking density, automated traffic lawenforce­ment, working or sleeping during your commute, the eliminatio­n of parking lots, decimated traffic accidents, and so on. Next, based on these first- order implicatio­ns, we can determine with fair certainty the second- order business opportunit­ies.

By tracking the convergenc­e of exponentia­l technologi­es, predicting initial implicatio­ns to industry, and then projecting the mid-term effects of those implicatio­ns, every business in any industry will be able to position its products and services for a 2025 or 2030 scenario, future-proofing its business model and leveraging the right technologi­cal tools to do so.

 ??  ?? Dr. Peter H. Diamandis Founder & Executive Chairman,
XPRIZE Foundation
Dr. Peter H. Diamandis Founder & Executive Chairman, XPRIZE Foundation

Newspapers in English

Newspapers from Canada